转移性癌症治疗市场(主要地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00017819
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

转移性癌症治疗市场预计在 2023 年至 2031 年期间的复合年增长率为 7.0%,市场规模将从 2023 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

报告按治疗适应症(乳腺癌、前列腺癌、肺癌、黑色素瘤、结直肠癌等)进行细分。报告按产品(品牌药物、仿制药)进行细分。全球分析进一步细分为区域和主要国家。报告以美元为单位提供上述分析和细分的价值。

报告目的

The Insight Partners 的《转移性癌症治疗市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

转移性癌症治疗市场细分

 

治疗指征

  • 乳腺癌
  • 前列腺癌
  • 肺癌
  • 黑色素瘤
  • 结直肠癌
  • 其他的

产品

  • 品牌药品
  • 仿制药

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

转移性癌症治疗市场:战略洞察

Metastatic Cancer Treatment Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

转移性癌症治疗市场的增长动力

  • 癌症发病率不断上升:全球癌症发病率是转移性癌症治疗市场增长的主要驱动力。根据世界卫生组织 (WHO) 的数据,癌症是全球最重要的死亡原因之一,每年有数百万新病例被发现。其中许多癌症已经发展到最近的转移阶段,这增加了对新治疗方案的需求。由于早期发现和诊断能力的提高,越来越多的患者被诊断出患有转移性疾病,这反过来又促进了市场的增长。
  • 靶向治疗和免疫治疗的进展:传统的化疗和放疗虽然有效,但会造成很多痛苦。这带来了治疗的革命,从这些传统做法转向所谓的靶向治疗,这种治疗只关注有缺陷的癌细胞,而不影响健康细胞,以及免疫疗法,这种疗法可以增强人体免疫系统对抗癌症的能力。药物开发方面取得了许多突破,例如免疫检查点抑制剂;派姆单抗和纳武单抗,因此这些药物推动了转移性癌症的使用和采用。
  • 老年人口:另一个驱动因素是全球人口老龄化加剧。随着寿命的延长,与年龄相关的疾病病例也随之增加,其中一些是癌症。转移性癌症很可能发生在老年患者中,因为随着年龄的增长,癌症很可能出现。这种人口结构变化导致人口比例对转移性癌症的专门治疗需求增加。这就是医疗保健系统如何调整以迎合老年人口中日益增加的癌症发病率,从而增加对转移性癌症领域有效治疗的需求。

转移性癌症治疗市场未来趋势

  • 以人为本的个性化医疗:个性化医疗/个性化医疗实际上正在恶性转移治疗场景中占据重要地位。这名患者在接受医生的治疗之前,已经发现了治疗概况和对肿瘤特征的信念发生了变化。
  • 肿瘤靶向联合治疗的治疗模式变化越来越频繁:事实上,联合治疗也已成为一个热门话题,由此引入了这种方法的各种组成部分,主要是从不同角度针对癌症。例如,化疗与免疫疗法相结合,用于治疗各种形式的转移性癌症。另一个有趣的方面是这些疗法的联合应用产生的协同效应,例如在传统疗法中加入靶向治疗。
  • 免疫肿瘤学覆盖范围:免疫肿瘤学通过提供免疫系统来对抗癌症。其中最大的部分是检查点抑制剂和 CAR T 细胞疗法的可能性,而中心则着眼于癌症疫苗的未来。目前,正在进行的关于免疫肿瘤学药物的临床试验显示出对控制转移性癌症的巨大效力,并加速了该分支向转移性癌症免疫疗法的转变。这种医学趋势的预期未来肯定会在转移性癌症的生存和缓解期上升。

转移性癌症治疗市场机会

  • 新型疗法的开发:在针对转移性癌症的领域,开发新型药物的机会非常广阔。在免疫疗法、基因疗法和 CRISPR 治疗等应用领域设计下一代药物的公司必将取得长足进步。机会在于评估与癌症和药物开发有关的新途径,这些途径可以防止转移性疾病扩散到身体的其他部位。
  • 新兴市场:转移性癌症治疗市场主要在工业化程度较高的地区发展;然而,随着亚太、拉丁美洲和非洲国家医疗保健渠道的增加、基础设施的改善和癌症意识的提高,新兴市场将提供巨大的机会。那些能够更好地调整其产品以满足这些市场的需求并提供负担得起的治疗的人会发现他们的需求激增。
  • 生物标志物驱动的治疗:生物标志物在转移性癌症病理学和治疗中的应用显著增加,创造了一个独特的机会。生物标志物驱动的治疗发展为正确的患者在正确的时间为正确的患者提供精准药物,从而降低毒性并最大程度地提高疗效。参与生物标志物发现和靶向治疗产品开发的公司将找到有利于其增长的市场机会。

 

转移性癌症治疗市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响转移性癌症治疗市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的转移性癌症治疗市场细分和地理位置。

Metastatic Cancer Treatment Market
  • 获取转移性癌症治疗市场的区域特定数据

转移性癌症治疗市场报告范围

报告属性细节
2023 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2023 - 2031)7.0%
史料2021-2022
预测期2024-2031
涵盖的领域根据治疗适应症
  • 乳腺癌
  • 前列腺癌
  • 肺癌
  • 黑色素瘤
  • 结直肠癌
  • 其他的
按产品分类
  • 品牌药品
  • 仿制药
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 霍夫曼-罗氏公司
  • 诺华公司
  • 默克
  • 礼来公司
  • 强生
  • 辉瑞
  • 阿斯利康
  • 葛兰素史克
  • 太阳制药

 

转移性癌症治疗市场参与者密度:了解其对业务动态的影响

转移性癌症治疗市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在转移性癌症治疗市场运营的主要公司有:

  1. 霍夫曼-罗氏公司
  2. 诺华公司
  3. 默克
  4. 礼来公司
  5. 强生

免责声明上面列出的公司没有按照任何特定顺序排列。


Metastatic Cancer Treatment Market

 

  • 了解转移性癌症治疗市场顶级关键参与者概况

 

 

主要卖点

 

  • 全面覆盖:该报告全面涵盖了转移性癌症治疗市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,转移性癌症治疗市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment accounts for highest revenue by Therapeutic Indications in 2023?

Breast Cancer segment, by Therapeutic Indications, dominated the market in 2023.

Which are some of the players operating in the Metastatic Cancer Treatment market?

Players operating in the market are F. HOFFMANN-LA ROCHE LTD, NOVARTIS AG, MERCK, ELI LILLY AND COMPANY, JOHNSON AND JOHNSON, PFIZER, ASTRAZENECA, GLAXOSMITHKLINE, SUN PHARMACEUTICAL, BAYER

What are the factor that act as a opportunity for market growth?

Development of Novel Therapeutics act as a opportunity for growth of the market in forecast period.

Which region dominated the Metastatic Cancer Treatment market in 2023?

North America region dominated the Metastatic Cancer Treatment market in 2023.

What is the expected CAGR of the Metastatic Cancer Treatment Market?

The Metastatic Cancer Treatment Market is estimated to witness a CAGR of 7.0% from 2023 to 2031

What are the driving factors impacting the Metastatic Cancer Treatment market?

The major factors driving the Metastatic Cancer Treatment market are:

1. Growing incidence of cancer

2. Targeted and Immunotherapy Treatment Advancements

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

1. HOFFMANN-LA ROCHE LTD
2. NOVARTIS AG
3. MERCK
4. ELI LILLY AND COMPANY
5. JOHNSON AND JOHNSON
6. PFIZER
7. ASTRAZENECA
8. GLAXOSMITHKLINE
9. SUN PHARMACEUTICAL
10. BAYER

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.